Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). Safety and Efficacy of Long‐Term Treatment with Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Touchstone Extension. American journal of gastroenterology. p. . [Online].